Enanta pharmaceuticals inc

Major-Pharmaceuticals

ENTA


500 Arsenal Street
Watertown , MA 02472

Executive/
Director

Price

  • Last Close
  • $ 8
    $ -0.01 -0.19 %
    Dec 6, 2024
  • 52-Week High/Low
  • $17.42 - $8.18
  • YTD
  • -15%

  • Trading Volume
  • 6,033
  • Market Cap Full
  • $ 168.5M
  • Shares Outstanding
  • 21.1M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -39.8% -11.1% -8.1% 37.9% 34.9% -5% 17.2% -4.8% -13.1% 85.6%
Q2 46.9% -24.9% 16.8% 41.4% -11.6% 4% -10.8% -33.6% -47.1% -1.8%
Q3 -19.7% 20.7% 30.1% -29.5% -27.2% 8% 29.1% 9.7% -47.8% -
Q4 -8.6% 25.9% 23.4% -15.8% 2.3% -8% 31.6% -10.3% -10.3% -
J F M A M J J A S O N D
2024 29.1% 18.3% 21.5% -4.3% - - - - - - - -
2023 14.8% -9.1% -16.6% -12.1% -34% -8.9% -11.4% -21.7% -24.8% -19.3% 3.6% 0.8%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    86%-35%1%75%21%-12%-32%78%-38%-80%-15%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.49 0.09 0.28 0.61 0.2 -0.3 -1.09 -1.63 -1.79
Q2 0.13 0.06 0.44 0.97 0.33 -0.71 -1.19 -1.53 -1.86
Q3 0.29 0.09 1.86 1.31 0.44 -1.45 -1.23 -1.27 -1.34
Q4 1.36 0.26 0.78 1.25 0.65 -0.41 -1.48 -1.39 -
A 3.3 0.5 3.4 3.5 2.2 -1.8 -3.9 -5.9 -4.99

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar 19.2 19.4 19.9 20.2 20.5 20.9
Jun 19.3 19.7 20 20.2 20.7 21.1
Sep 19.4 19.7 20.1 20.2 20.7 21.1
Dec 19.4 19.7 20.1 20.3 20.8 21.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 2.2 0.8 2.8 2.7 6.1
Total Asset Turnover 0.2 0.2 0.3 0.4 0.5
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 62 3.6 7 -4.1 5.4
Equity multiplier 0.1 0.3 0.1 0.2 0.1